Laser therapy of vascular lesions

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 6, 2006, Pages 324-332

  Landthaler, Michael ^a   Hohenleutner, U ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

FPDL; Haemangioma; IPL; LPTDL; Nd; PWS; Teleangiectasia; Vascular malformations; YAG

Indexed keywords

APPLICATION SITE HYPERPIGMENTATION; ARGON LASER; DERMATOLOGY; DIODE LASER; HEMANGIOKERATOMA; HEMANGIOMA; HUMAN; HYPERTROPHIC SCAR; HYPOPIGMENTATION; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; LYMPHANGIOMA; NEODYMIUM LASER; NEVUS; NEVUS FLAMMEUS; POIKILODERMA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PULSED DYE LASER; PYOGENIC GRANULOMA; RADIATION DOSE; REVIEW; SCLEROTHERAPY; SKIN ATROPHY; SKIN BLOOD VESSEL; SKIN DEFECT; TELANGIECTASIA; TREATMENT INDICATION; VASCULAR LESION; VEIN MALFORMATION;

ADULT; FACIAL DERMATOSES; FEMALE; HEMANGIOMA; HUMANS; LASER THERAPY, LOW-LEVEL; LYMPHANGIOMA; NEOPLASMS, VASCULAR TISSUE; PORT-WINE STAIN; SEVERITY OF ILLNESS INDEX; TELANGIECTASIS;

EID: 33750812554     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00254.x     Document Type: Review

References (86)

1. Landthaler M, Ulrich H, Hohenleutner S, Wimmershoff M, Hohenleutner U. Role of laser therapy in dermatology -clinical aspects. Dermatology 2004; 208: 129-134.
2. Ross EV, Smirnov MZ, Pankratov M, Altshuler GB. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: Some theoretical and practical comparisons. Dermatol Surg 2005; 31: 1188-1198.
3. Lorenz S, Maier C, Segerer H, Landthaler M, Hohenleutner U. Hautveränderungen bei Neugeborenen in den ersten 5 Lebenstagen. Hautarzt 2000; 51: 396-400.
4. Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527.
5. Tomson N, Lim SPR, Abdullah AN, Lanigan SW. The treatment of port-wine stains with the pulsed-dye laser at 2-week and 6-week intervals: A comparative study. Br J Dermatol 2006; 154: 676-679.
6. Katugampola GA, Lanigan SW. Laser treatment of port-wine stains: therapeutic outcome in relation to morphological parameters. Br J Dermatol 1997; 136: 467-468.
7. Levine VJ, Geronemus RG. Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: A study of 500 patients. J Am Acad Dermatol 1995; 32: 613-617.
8. Wlotzke U, Hohenleutner U, Abd-El Raheem TA, Bäumler W, Landthaler M. Side-effects and complications of flashlamp-pumped pulsed dye laser therapy of port-wine stains. A prospective study. Br J Dermatol 1996; 134: 475-480.
9. Willey A, Anderson RR, Azpiazu JL, et al. Complications of laser dermatologic surgery. Lasers Surg Med 2006; 38: 1-15.
10. Orten SS, Waner M, Flock S, Roberson PK, Kincannon J. Port wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg 1996; 122: 1174-1179.
11. Michel S, Landthaler M, Hohenleutner U. Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser. Br J Dermatol 2000; 143: 1230-1234.
12. Scherer K, Lorenz S, Wimmershoff MB, Landthaler M, Hohenleutner U. Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy. Br J Dermatol 2001; 145: 79-84.
13. Bernstein EF. Treatment of a resistant port-wine stain with the 1.5-msec pulse duration, tunable, pulsed dye laser. Dermatol Surg 2000; 26: 1007-1009.
14. Laube S, Taibjee S, Lanigan SW. Treatment of resistant port wine stains with the VBeam ® pulsed dye laser. Lasers Surg Med 2003; 33: 282-287.
15. Yung A, Sheehan-Dare R. A comparative study of a 595-nm with a 585-nm pulsed dye laser in refractory port wine stains. Br J Dermatol 2005; 153: 601-606.
16. Geronemus RG, Quintana AT, Lou WW, Kauvar AN. High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol 2000; 136: 942-943.
17. Chowdhury MMU, Harris S, Lanigan SW. Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol 2001; 144: 814-817.
18. Clark C, Cameron H, Moseley H, Ferguson JE. Treatment of superficial cutaneous vascular lesions: Experience with the KTP 532 nm laser. Lasers Med Sci 2004; 19: 1-5.
19. Lorenz S, Scherer K, Wimmershoff MB, Landthaler M, Hohenleutner U. Variable pulse frequency-doubled Nd: YAG laser versus flashlamp-pumped pulsed dye laser in the treatment of port wine stains. Acta Derm Venereol 2003; 83: 210-213.
20. Yang MU, Yaroslavsky AN, Farinelli WA, et al. Long-pulsed neodymium: yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol 2005; 52: 480-490.
21. Strempel H, Klein W. Laser therapy without laser: A controlled trial comparing the flashlamp-pumped dye laser with the Photoderm high-energy gas discharge lamp. Lasers Med Sci 1996; 11: 185-187.
22. Raulin C, Schroeter CA, Weiss RA, Keiner M, Werner S. Treatment of port-wine stains with a noncoherent pulsed light source. A retrospective study. Arch Dermatol 1999; 135: 679-683.
23. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther 2003; 5: 7-13.
24. Ho W-S, Ying S-Y, Chan PC, Chan HH. Treatment of port wine stains with Intense Pulsed Light: A prospective study. Dermatol Surg 2004; 30: 887-891.
25. Reynolds N, Exely J, Hills S, Falder S, Duff C, Kenealy J. The role of the Lumina intense pulsed light system in the treatment of port wine stains -a case controlled study. Br J Plast Surg 2005; 58: 968-980.
26. Cliff S, Misch K. Treatment of mature port wine stains with the PhotoDerm VL. J Cutan Laser Ther 1999; 1: 101-104.
27. Hohenleutner S, Badur-Ganter E, Landthaler M, Hohenleutner U. Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: An evaluation of 617 cases. Lasers Surg Med 2001; 28: 273-277.
28. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood hemangiomas: Results of a 1-year analysis. Lancet 2002; 360: 521-527.
29. Hohenleutner U, Landthaler M. Laser treatment of childhood hemangioma -progress or not? Lancet 2002; 360: 502-503.
30. Tanaka R, Miyasaka M, Taira H, Tanino R. Comparison of pulsed dye laser and wait and see policy in treatment of childhood hemangioma. Lasers Surg Med 2005; 17: 35.
31. Kono T, Kawate H, Kikuchi Y, Nozaki M. Comparison study of traditional dye and long-pulsed dye laser in the treatment of early haemangiomas. Lasers Surg Med 2005; 17: 36.
32. Landthaler M, Hohenleutner U, Abd-El Raheem TA. Laser therapy of childhood hemangiomas. Br J Dermatol 1995; 133: 275-281.
33. Ulrich H, Bäumler W, Hohenleutner U, Landthaler M. Neodymium-YAG laser for hemangiomas and vascular malformations -long term results. J Dtsch Dermatol Ges 2005; 3: 436-440.
34. Groot D, Rao J, Johnston PA, Nakatsui T. Algorithm for using a long-pulsed Nd: YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg 2003; 29: 35-42.
35. Landthaler M, Haina D, Waidelich W, Braun-Falco O. Behandlung zirkumskripter Lymphangiome mit dem Argonlaser. Hautarzt 1982; 33: 266-270.
36. Landthaler M, Hohenleutner U, Braun-Falco O. Acquired lymphangioma of the vulva: Palliative treatment by means of carbon dioxide laser vaporization. Arch Dermatol 1990; 126: 967-968.
37. Huilgol SC, Neill S, Barlow RJ. CO2 laser therapy of vulval lymphangiectasia and lymphangioma circumscriptum. Dermatol Surg 2002; 28: 575-577.
38. Adrian RM, Tanghetti EA. Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 1998; 24: 71-74.
39. Goldberg DJ, Meine JG. A comparison of four frequency-doubled Nd: YAG (532nm) laser systems for treatment of facial telangiectasias. Dermatol Surg 1999; 25: 463-467.
40. Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd. YAG laser a prospective study of 17 patients. Dermatol Surg 2002; 28: 244-247.
41. Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different intense pulsed light (IPL) wavelength bands. Lasers Surg Med 2004; 34: 120-126.
42. Clementoni MT, Gilardino P, Muti GF, et al. Facial teleangiectasias: Our experience in treatment with IPL. Lasers Surg Med 2005; 37: 9-13.
43. Gottschaller C, Hohenleutner U, Landthaler M. Lasertherapie oberflächlicher vaskulärer Hautveränderungen: IPL-Systeme versus Argon- und Farbstofflaser. J Dtsch Dermatol Ges 2005; 3: 141.
44. Hohenleutner U, Wenig M, Walther T, Bäumler W, Landthaler M. Behandlung von Besenreisern mit einem blitzlampengepumpten gepulsten Farbstofflaser mit 1,5 ms Impulsdauer. Hautarzt 1998; 49: 560-565.
45. Hohenleutner U, Walther T, Wenig M, Bäumler W, Landthaler M. Leg Telangiectasia with a 1.5 ms pulsed dye laser, ice cube cooling of the skin and 595 vs. 600 nm: Preliminary results. Lasers Surg Med 1998; 23: 72-78.
46. Kono T, Yamaki T, Ercöcen AR, Fujiwara O. Treatment of leg veins with the long pulse dye laser using variable pulse durations and energy fluences. Lasers Surg Med 2004; 35: 62-67.
47. Kauvar AN, Lou WW. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol 2000; 136: 1371-1375.
48. Eremia S, Li C, Umar SH. A side-by-side comparative study of 1064 YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg 2002; 28: 224-230.
49. Kaudewitz P, Klövekorn W, Rother W. Effective treatment of leg vein telangiectasia with a new 940 nm diode laser. Dermatol Surg 2001; 27: 101-106.
50. Kaudewitz P, Klövekorn W, Rother W. Treatment of leg vein telangiectases: 1-year results with a new 940 nm diode laser. Dermatol Surg 2002; 28: 1031-1034.
51. Levy JL, Berwald C. Treatment of vascular abnormalities with a long-pulse diode at 980 nm. J Cosmet Laser Ther 2004; 6: 217-221.
52. Passeron T, Olivier V, Duteil L, Desruelles F, Fontas E, Ortonne J-P. The new 940-nm diode laser: An effective treatment for leg venulectasia. J Am Acad Dermatol 2003; 48: 768-774.
53. Spendel S, Prandl EC, Schintler MV, et al. Treatment of spider leg veins with the KTP (532 nm) laser -a prospective study. Lasers Surg Med 2002; 31: 194-201.
54. Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment of leg veins using Nd: YAG lasers at 1064 nm. Br J Dermatol 2006; 155: 364-371.
55. Mordon S, Brisot D, Fournier N. Using a "non uniform pulse sequence"can improve selective coagulation with a Nd: YAG laser (1.06 μm) thanks to Met-Hemoglobin absorption: A clinical study on blue leg veins. Lasers Surg Med 2003; 32: 160-170.
56. Levy JL, Elbahr C, Jouve E, Mordon S. Comparison and sequential study of long pulsed Nd: YAG 1064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med 2004 ; 34: 273-276.
57. Lupton JR, Alster TS, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd: YAG laser treatment for lower extremity telangiectases. Dermatol Surg 2002; 28: 694-697.
58. Omura NE, Dover JS, Arndt KA, Kauvar AN. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd: YAG laser. J Am Acad Dermatol 2003; 48: 76-81.
59. Raskin B, Fany RR. Laser treatment for neovascular formation. Lasers Surg Med 2004; 34: 189-192.
60. Rogachewsky AS, Silapunt S, Goldberg DJ. Nd: YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins efficacy as measured by vessel color and size. Dermatol Surg 2002; 28: 220-223.
61. Sadick NS, Prieto VG, Shea CR, Nicholson J, McCaffrey T. Clinical and pathophysiologic correlates of 1046-nm Nd: YAG laser treatment of reticular veins and venulectasias. Arch Dermatol 2001; 137: 613-617.
62. Trelles MA, Allones I, Martin-Vasquez MJ, Trelles OR, Velez M, Mordon S. Long pulse Nd: YAG laser for treatment of leg veins in 40 patients with assessments at 6 and 12 months. Lasers Surg Med 2004; 35: 68-76.
63. Coles CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laeser and sclerotherapy. Lasers Surg Med 2002; 30: 154-159.
64. Navarro L, Min RJ, BonéC. Endovenous laser: A new minimally invasive method of treatment for varicose veins -preliminary observations using an 810 nm diode laser. Dermatol Surg 2001; 27: 117-122.
65. Weiss RA, Munavalli G, Bellew SG. Comparison of endovenous saphenous vein obliteration techniques: 810 nm versus 1320 nm versus radiofrequency. Lasers Surg Med 2005; 36: 17.
66. Chang CJ, Chua JJ. Endovenous laser photocoagulation (EVLP) for varicose veins. Lasers Surg Med 2002; 31: 257-262.
67. Goldman MP, Mauricio M, Rao J. Intravascular 1320-nm laser closure of the great saphenous vein: A 6- to 12-month follow-up study. Dermatol Surg 2004; 30: 1380-1385.
68. Kluner C, Fischer T, Filimonow S, Hamm B, Kröncke T. Die endovasale Lasertherapie varikös veränderter Stammvenen: Eine effektive und komplikationsarme Alternative zum Venenstripping. Fortschr Röntgenstr 2005; 177: 179-187.
69. Oh CK, Jung DS, Jang HS, Kwon KS. Endovenous laser surgery of the incompetent greater saphenous vein with a 980-nm diode laser. Dermatol Surg 2003; 29: 1135-1140.
70. Parente EJ, Rosenblatt M. Endovenous laser treatment to promote venous occlusion. Lasers Surg Med 2003; 33: 115-118.
71. Proebstle TM. Endovenöse Lasertherapie der Varikose. Phlebologie 2003; 32: 131-137.
72. Proebstle TM, Pannier FM, Schuller-Petrovic S, Offermann M, Hohenleutner U, Rabe E. Konsensus zur endovenösen Lasertherapie der Varikose. Phlebologie 2004; 33: 106-109.
73. Proebstle TM, Krummenauer F, Gül D, Knop J. Nonocclusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg 2004; 30: 174-178.
74. Lurie F, Creton D, Eklof B, et al. Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): Two-year follow-up. Eur J Vasc Endovasc Surg 2005; 29: 67-73.
75. Morrison N. Saphenous ablatio: What are the choices, laser or RF energy? Semin Vasc Surg 2005; 18: 15-18.
76. Landthaler M, Haina D, Waidelich W, Braun-Falco O. Laser therapy of venous lakes (Bean-Walsh) and telangiectasias. Plast Reconstr Surg 1984; 73: 78-83.
77. Lorenz S, Landthaler M, Hohenleutner U. Vaskuläre Fehlbildung der Zunge: Therapie mittels Nd: YAG-Laser. In: Müller RPA, Mailänder W, Brand L, eds. Seltene Tumoren der Haut. Fortschritte der Operativen Dermatologie. Berlin: Congress Compact Verlag, 2003; 185-187.
78. Wimmershoff MB, Landthaler M, Hohenleutner U. Percutaneous and combined percutaneous and intralesional Nd: YAG-laser therapy for vascular malformations. Acta Derm Venereol 1999; 79: 71-73.
79. Raulin C, Werner S. Treatment of venous malformations with an intense pulsed light source (IPLS) technology: A retrospective study. Lasers Surg Med 1999; 25: 170-177.
80. Gorse SJ, James W, Murison MSC. Successful treatment of angiokeratoma with potassium tritanyl phosphate laser. Br J Dermatol 2004; 150: 620-621.
81. Bechara FG, Jansen T, Wilmert M, Altmeyer P, Hoffmann K. Angiokeratoma Fordyce of the glans penis: Combined treatment with Erbium: YAG and 532 nm KTP (frequency doubled neodymium:YAG) laser. J Dermatol 2004; 31: 943-945.
82. Yang CH, Ohara K. Successful surgical treatment of verrucous hemangioma: a combined approach. Dermatol Surg 2002; 28: 913-920.
83. Goldman MP, Weiss RA. Treatment of poikiloderma of Civatte on the neck with an intense pulsed light source. Plast Reconstr Surg 2001; 107: 1376-1381.
84. Weiss RA, Goldman MP, Weiss MA. Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol Surg 2000; 26: 823-828.
85. Raulin C, Greve B. IPL technology: A review. Lasers Surg Med 2003; 32: 78-87.
86. Geronemus RG. Treatment of spider telangiectases in children using the flashlamp-pumped pulsed dye laser. Pediatr Dermatol 1991; 8: 61-63.